FundedIQ
Biotechnology

Beckley Psytech: Funding, Investors & Team (Oct 2026)

Beckley Psytech is a company focused on utilizing psychedelic substances like psilocybin and other compounds for mental health treatment. Their objective is to integrate clinically proven psychedelic medicines into current medical practices, aiming to assist individuals dealing with depression and other neuropsychiatric conditions that lack effective treatment options.

www.beckleypsytech.com LinkedIn Beckley, United Kingdom 51-100 employees
Total raised
$40.0M
Rounds
1
Latest
Undisclosed round
Jan 2024

Beckley Psytech has raised $40.0M across 1 funding round on record, the most recent an undisclosed round of $40.0M announced in Jan 2024.

That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Beckley Psytech Company Profile and Key Stats

Total funding raised
$40.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$40.0M in Jan 2024
Employees
51-100
reported band
Headquarters
Beckley, United Kingdom

Latest funding round on record: Jan 2024.

Beckley Psytech Funding Rounds

Date
Round
Amount
Undisclosed round
$40.0M

Beckley Psytech Founders and Leadership Team

Name
Role
Contact
Lady Amanda Feilding
Founder
—

No contact details are on record for this team yet.

Beckley Psytech Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
5,343
$4.1M

Beckley Psytech's latest round of $40.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Beckley Psytech in Biotechnology and Beckley

Companies Similar to Beckley Psytech

R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…

Series A $3.0M

The perfect package for any general surgical trainee or resident. Progress from beginner to advanced surgical…

Undisclosed round $9.3M

Argonaute RNA company research projects build on existing intellectual property.

Undisclosed round $1.8M

An innovative C elegans company that serves the biotech, nutrition, and other industries and fields of study…

Undisclosed round $1.8M

ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…

Undisclosed round $23.3M

Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…

Series A $33.6M

Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…

Undisclosed round $3.5M

Concert Bio helps businesses create optimal microbial communities.

Undisclosed round $130k

RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…

Series A $113M

N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…

Undisclosed round $3.6M

Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…

Undisclosed round $3.0M

Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.

Series A $32.5M

Beckley Psytech Funding FAQs

What does Beckley Psytech do?

Beckley Psytech is a company focused on utilizing psychedelic substances like psilocybin and other compounds for mental health treatment. Their objective is to integrate clinically proven psychedelic medicines into current medical practices, aiming to assist individuals dealing with depression and other neuropsychiatric conditions that lack effective treatment options.

How much funding has Beckley Psytech raised?

Beckley Psytech has raised $40.0M across 1 round on record. The most recent is an undisclosed round of $40.0M announced in Jan 2024.

When did Beckley Psytech last raise funding?

Beckley Psytech's most recent funding round on record is an undisclosed round of $40.0M, announced in Jan 2024.

Who founded Beckley Psytech?

FundedIQ lists Lady Amanda Feilding (Founder) at Beckley Psytech.

Where is Beckley Psytech headquartered?

Beckley Psytech is based in Beckley, Oxfordshire, United Kingdom.

How many employees does Beckley Psytech have?

Beckley Psytech is in the 51-100 employee band.

How does Beckley Psytech's funding compare to other Biotechnology startups?

Beckley Psytech's latest round of $40.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Beckley Psytech Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Beckley Psytech is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.